logo

$5 And Under

Share SHARE

Synacor Inc. (SYNC) announced after the bell Wednesday that it has been awarded a portal services contract by AT&T (T). Synacor has gapped open dramatically higher Thursday morning and is now up 2.34 at $3.75 on the highest volume of the year. The stock has soared to a new high for the year.

AXT Inc. (AXTI) reported first quarter EPS of $0.00 after the bell Monday, compared to the loss of $0.04 in the previous year. Revenues rose to $18.7 million from $18.1 million last year. AXT has spiked sharply to the upside at the open Tuesday and is currently higher by 1.03 at $3.68 on the highest...

BIND Therapeutics Inc. (BIND) announced Monday morning that it has filed a voluntary petition under Chapter 11 of the Bankruptcy Code. BIND Therapeutics gapped open sharply lower Monday and fell during the first half hour of trade, before settling into a range. The stock closed down by 1.07 at $0.38...

BIND Therapeutics Inc. (BIND) announced Monday morning that it has filed a voluntary petition under Chapter 11 of the Bankruptcy Code. BIND Therapeutics gapped open sharply lower this morning and has continued to lose ground in early trade. Shares are now down 1.04 at $0.41 on the highest volume...

Dehaier Medical Systems (DHRM) announced Thursday morning that Liaison Interactive has agreed to purchase 11,111,111 restricted common shares of the company for US$20,000,000. Dehaier Medical Systems has been rising sharply since the announcement and is now up 1.35 at $2.68. The stock has surged...

Resonant Inc. (RESN) announced Wednesday morning that it has signed its first licensing agreement with an existing customer. Resonant gapped open higher Wednesday and has taken out the highs of the morning in the last few minutes. The stock is now up 1.23 at $4.62 on the highest volume in over 10...

TrovaGene Inc. (TROV) announced Monday morning that William (Bill) Welch was appointed as its new CEO, effective immediately. The company also announced that its Chief Commercial Officer, Matthew Posard, has left the company. TrovaGene gapped open lower Monday and declined throughout the session....

The Container Store Group (TCS) reported fourth quarter EPS of $0.20 after the bell Monday, compared to $0.24 in the previous year. Revenues rose to $232.1 million. The consensus estimates were for EPS of $0.21 and revenues of $230.53 million. The stock is now up 1.22 on 200K shares. The Container...

Aratana Therapeutics Inc. (PETX) announced after the bell Monday that Elanco Animal Health has licensed animal health rights to Aratana's Galliprant. Elanco is a division of Eli Lilly & Co. (LLY). Aratana Therapeutics fell during the first 45 minutes of trade Monday and slipped further in the early...

Advanced Micro Devices (AMD) reported a first quarter loss of $0.12 per share after the bell Thursday, compared to the loss of $0.09 per share a year ago. Analysts expected a loss of $0.13 per share. Lisa Su, AMD CEO, said "We are optimistic about our growth prospects in the second half of the year...

Calumet Specialty Products Partners (CLMT) announced after the close Friday that it has suspend its current quarterly cash distribution of $0.685 per unit, effective for the quarter. The company also announced that it expects to report a first quarter net loss between $83.0 million and $59.0 million. Calumet...

Chiasma Inc. (CHMA) announced Monday morning that it has received a complete response letter from the FDA regarding its New Drug Application for Mycapssa capsules. Chiasma gapped open dramatically lower Monday, but traded in a range for the majority of the session. The stock ended the day with a loss...

Calumet Specialty Products Partners (CLMT) announced after the close Friday that it has suspend its current quarterly cash distribution of $0.685 per unit, effective for the quarter. The company also announced that it expects to report a first quarter net loss between $83.0 million and $59.0 million. Calumet...

Chiasma Inc. (CHMA) announced Monday morning that it has received a complete response letter from the FDA regarding its New Drug Application for Mycapssa capsules. Chiasma gapped open sharply lower this morning and is now down 6.21 at $3.95 on the highest volume in 9 months. The stock has dropped to a new all-time low.

Ignyta Inc. (RXDX) announced updated results of its Phase 1 clinical trials of entrectinib on Sunday. The results showed tumor regression in 80% of patients. Ignyta gapped open higher Monday and is now up 1.05 at $9.16 on above average volume. The stock has climbed to over a 2-month high.

Follow RTT